Comparative pharmacology of low molecular weight heparins : Implications of manufacturing processes on biological effects
- 1 August 1989
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 55 (4) , 419-426
- https://doi.org/10.1016/0049-3848(89)90050-9
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- What is the best plasmatic activity which could be correlated with the antithrombotic effect of heparin and a low molecular weight heparin fragment?Thrombosis Research, 1987
- Comparative Study on the Effects of a Low Molecular Weight Heparin (CY 216) and Standard Heparin in Low Dosage on Experimental Venous ThrombosisPathophysiology of Haemostasis and Thrombosis, 1987
- A sensitive model of venous thrombosis in ratsThrombosis Research, 1986
- ANTITHROMBOTIC EFFECT OF OP LMWH BY SUBCUTANEOUS ROUTE IN RATS1986
- A Modified Stasis Thrombosis Model to Study the Antithrombotic Actions of Heparin and Its FractionsSeminars in Thrombosis and Hemostasis, 1985
- A Comparison Between Low Molecular Weight Heparin (KABI 2165) and Standard Heparin in the Intravenous Treatment of Deep Venous ThrombosisThrombosis and Haemostasis, 1985
- Studies on the Antithrombotic Effects and Pharmacokinetics of Heparin Fractions and FragmentsSeminars in Thrombosis and Hemostasis, 1985
- Heparin and a low molecular weight fraction enhances thrombolysis and by this pathway exercises a protective effect against thrombosisThrombosis Research, 1983
- Failure of aspirin at different doses to modify experimental thrombosis in ratsThrombosis Research, 1980